Richard I Eisenstadt's Net Worth
$494 Thousand
Who is Richard I Eisenstadt?
Richard I Eisenstadt does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Altimmune, Inc., Neos Therapeutics, Inc., AYTU BIOPHARMA, INC, and TRANZYME INC.
SEC CIK
Richard I Eisenstadt's CIK is 0001515806
Past Insider Trading and Trends
2023 was Richard I Eisenstadt's most active year for acquiring shares with 5 total transactions. Richard I Eisenstadt's most active month to acquire stocks was the month of December. 2021 was Richard I Eisenstadt's most active year for disposing of shares, totalling 11 transactions. Richard I Eisenstadt's most active month to dispose stocks was the month of February. 2016 saw Richard I Eisenstadt paying a total of $25,283.65 for 53,710 shares, this is the most they've acquired in one year. In 2022 Richard I Eisenstadt cashed out on 15,528 shares for a total of $49,810.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Altimmune, Inc. (ALT) Snapshot price: $6.21
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.21% | 11.72K |
$6.25 | -$8,884.51 | 45.01K |
Jan 30 - Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +39.67% | 9.46K |
$11.25 | -$34,245.00 | 33.29K |
Dec 29
| |||
Form 4
| +8.29% | 1.82K |
$2.81 | $5,128.25 | 23.84K |
Jul 31
| |||
Form 4
| +10.81% | 1.17K |
$10.21 | $11,964.36 | 12.01K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
| +693.41% | 9.47K |
$16.45 | -$49,810.60 | 10.84K |
Dec 31
| |||
Form 4
|
∞
| 1.37K |
$6.86 | $9,370.76 | 1.37K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neos Therapeutics, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -126.25K |
—
|
—
|
0
|
Mar 19
| |||
Form 4
| -11.38% | -16.21K |
$0.85 | -$13,739.67 | 126.25K |
Mar 1 - Mar 2
| |||
Form 4
|
∞
| 100K |
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +13.35% | 5K |
$2.16 | $10,819.50 | 42.46K |
Dec 12
| |||
Form 4
| +100.21% | 18.75K |
—
|
—
| 37.46K |
Mar 1
| |||
Form 4
| +404.31% | 15K |
—
|
—
| 18.71K |
May 1
| |||
Form 4
|
∞
| 3.71K |
$6.82 | $25,283.65 | 3.71K |
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AYTU BIOPHARMA, INC (AYTU) Snapshot price: $2.48
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +400.47% | 55K |
—
|
—
| 68.73K |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TRANZYME INC No price found
VP, Finance & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||